503B outsourcing facilities operate under the most rigorous pharmaceutical quality requirements in the US regulatory framework — annual FDA inspections, full cGMP compliance under 21 CFR Part 211, and USP sterile compounding standards. Affinity QMS is the only platform built with PCAB accreditation support and sterile compounding workflow configuration from the ground up.
503B outsourcing facility QMS · Compounding pharmacy compliance · USP 797 compliance · PCAB accreditation support · From $499/mo
503B outsourcing facilities face a uniquely complex regulatory landscape: full pharmaceutical cGMP under 21 CFR Part 211, FDA-specific 503B guidance documents, and USP chapter requirements for sterile and hazardous drug compounding. Affinity QMS maps all three frameworks into a unified quality system.
Current Good Manufacturing Practice — Finished Pharmaceuticals
503B outsourcing facilities are held to full pharmaceutical cGMP standards — the same regulatory framework as commercial drug manufacturers. Affinity QMS maps every 21 CFR Part 211 subpart to documented workflows: personnel qualifications, batch records, deviation investigation, complaint management, and annual product review.
FDA Drug Shortage & Registration Requirements
FDA has issued multiple guidance documents specific to 503B outsourcing facilities — covering which bulk drug substances can be compounded, drug shortage conditions, and registration requirements. Affinity QMS keeps your quality system aligned with current FDA guidance, not just the baseline cGMP regulation.
Pharmaceutical Compounding — Sterile Preparations
USP <797> sets the standards for environmental monitoring, personnel competency, sterility testing, and beyond-use dating for sterile compounding. Affinity QMS structures your environmental monitoring program documentation, media fill records, and end-product testing — all traceable and retrievable at inspection.
Hazardous Drug Handling & Pharmacy Compounding Accreditation
USP <800> governs the safe handling of hazardous drugs throughout your facility. PCAB accreditation — the gold standard for compounding pharmacies — requires a documented quality management system covering training, environmental monitoring, and complaint management. Affinity QMS is the only QMS platform with built-in PCAB accreditation workflow configuration.
503B outsourcing facilities require the most comprehensive quality system of any regulated industry. Affinity QMS activates every required module in a connected, validated platform — no separate systems, no integration projects.
Annual FDA Inspection Readiness — Continuous, Not Reactive
503B facilities are inspected by FDA on an annual cycle — which means your audit readiness cannot be a once-a-year scramble. Affinity QMS maintains your CAPA log, deviation records, environmental monitoring documentation, and training records in a continuously updated, inspection-ready state. Your team should be able to walk an FDA investigator through your quality system on any day of the year. Learn more about Audit Management →
503B Registration Complexity — Demonstrating Current GMP Compliance to FDA During Registration Review
503B registration requires demonstrating that your facility is operating in compliance with cGMP before FDA will accept your outsourcing facility registration. Most applicants underestimate how mature their quality system needs to be at registration. Affinity QMS builds your quality infrastructure fast enough to support the registration timeline — with a documented, functional QMS that FDA expects to see, not one you're planning to build.
Sterile Compounding Documentation — Environmental Monitoring, Media Fills, and End-Product Testing Traceability
USP <797> requires a comprehensive environmental monitoring program: routine surface and air sampling, personnel monitoring, and immediate investigation when action limits are exceeded. Media fill documentation must be linked to the batch records for every batch produced during the qualification period. End-product sterility testing results must be traceable to each lot released. Managing this in disconnected spreadsheets or paper systems is how FDA Form 483 observations happen.
FDA Inspection Frequency — 503B Facilities Face Annual FDA Inspections; Audit Readiness Must Be Continuous
Unlike most FDA-regulated manufacturers who see an inspector every few years, 503B outsourcing facilities are on an annual inspection cycle. There is no "off season" for audit readiness. Affinity QMS is built around continuous readiness — every record is controlled, every CAPA is tracked to closure, every deviation is investigated and resolved. When the investigator calls on a Monday to say they'll be there Wednesday, you're ready.
Affinity QMS supports the full certification and accreditation roadmap for 503B outsourcing facilities — from initial FDA registration through PCAB accreditation and USP chapter compliance.
503B facilities outgrow generic pharma QMS tools quickly.
Generic pharmaceutical QMS platforms were built for commercial drug manufacturers — not for the specific documentation requirements of sterile compounding at scale. When a 503B facility tries to configure a standard pharma QMS for USP <797> environmental monitoring programs or PCAB-specific accreditation requirements, they spend more time on configuration than on compliance. Affinity QMS is the only platform with built-in PCAB accreditation support and sterile compounding workflow configuration — meaning your quality team spends time running the program, not building the software around it. And when you're ready to expand into ISO 17025 lab accreditation for your in-house testing program, the same platform handles it.
See how Affinity QMS gives 503B outsourcing facilities a continuously audit-ready quality system — with built-in PCAB accreditation support and sterile compounding workflow configuration.